Tomo Marjanovic says tirzepatide and retatrutide are not GLP2 or GLP3 drugs
His point: the number people attach to these drugs counts how many receptors the molecule hits, not a different hormone. A quick correction of a common naming mix-up.
Recap by typeshit. Post by @tomo_marjanovic on Instagram.